Corbus Pharmaceuticals Holdings Inc
F:337
Corbus Pharmaceuticals Holdings Inc
F:337
Price:
4.338
EUR
Market Closed
Market Cap:
€18.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Corbus Pharmaceuticals Holdings Inc
F:337
|
US |
|
B
|
BCPG PCL
SET:BCPG
|
TH |
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
Takeda Pharmaceutical Co Ltd
F:TKD
|
JP |
|
XP Factory PLC
F:1EQ
|
UK |
|
B
|
Bukit Sembawang Estates Ltd
XMUN:B1W1
|
SG |
Wall St Price Targets
Price Targets Summary
Corbus Pharmaceuticals Holdings Inc
Corbus Pharmaceuticals Holdings Inc
Wall Street analysts forecast Corbus Pharmaceuticals Holdings Inc stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for Corbus Pharmaceuticals Holdings Inc is 18.253 EUR with a low forecast of 13.556 EUR and a high forecast of 26.172 EUR.
Lowest Forecast
Price Target
13.556
EUR
212% Upside
Average Forecast
Price Target
18.253
EUR
321% Upside
Highest Forecast
Price Target
26.172
EUR
503% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Corbus Pharmaceuticals Holdings Inc's stock price target?
Price Target
18.253
EUR
18.253
EUR
According to Wall Street analysts, the average 1-year price target for Corbus Pharmaceuticals Holdings Inc is 18.253 EUR with a low forecast of 13.556 EUR and a high forecast of 26.172 EUR.
